A non-DRE, voided urine, genomic assay to diagnose prostate cancer and to assess its aggressiveness.
Comparing NCCN-based risk groups to the PROTEUS definition of high-risk localized prostate cancer to inform peri-operative care.
Early prostate evaluation can detect enlarged prostate and cancer before symptoms worsen, says Dr. Piyush Varshney of Fortis Hospital Noida.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results